Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 2646.00 | 4356.25 | 0.6074 | 0.1116 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 2500.00 | 2418.67 | 1209.00 | 4356.25 | 0.2775 | -0.5582 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4346.00 | 4356.25 | 0.9977 | 0.9945 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4309.00 | 4356.25 | 0.9892 | 0.9745 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5506.00 | 5895.50 | 0.9339 | 0.7552 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5825.00 | 5895.50 | 0.9880 | 0.9546 | |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 3 | 5000.00 | 4101.40 | 5835.00 | 5895.50 | 0.9897 | 0.9610 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 5927.00 | 5895.50 | 1.0053 | 1.0205 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 2919.00 | 5895.50 | 0.4951 | -0.4778 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 3383.00 | 5895.50 | 0.5738 | -0.3078 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 5634.00 | 5895.50 | 0.9556 | 0.8340 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 6017.00 | 5895.50 | 1.0206 | 1.0795 | |
| SK-BR-3 | Palbociclib | 0.01 | uM | 3 | 5000.00 | 4101.40 | 5671.00 | 5895.50 | 0.9619 | 0.8570 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 5000.00 | 4101.40 | 5979.00 | 5895.50 | 1.0142 | 1.0545 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 2241.00 | 5895.50 | 0.3801 | -0.6848 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5817.00 | 5895.50 | 0.9867 | 0.9494 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 5000.00 | 4101.40 | 2959.00 | 5895.50 | 0.5019 | -0.4640 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 5000.00 | 4101.40 | 5312.00 | 5895.50 | 0.9010 | 0.6390 |
| SK-BR-3 | Taxol | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 2241.00 | 5895.50 | 0.3801 | -0.6848 |
| SK-BR-3 | Taxol | 1 | uM | 3 | 5000.00 | 4101.40 | 2017.00 | 5895.50 | 0.3421 | -0.7422 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 2230.00 | 5895.50 | 0.3783 | -0.6878 |
| SK-BR-3 | Palbociclib | 10 | uM | 3 | 5000.00 | 4101.40 | 3969.00 | 5895.50 | 0.6732 | -0.0608 |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 5000.00 | 4101.40 | 2814.00 | 5895.50 | 0.4773 | -0.5131 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5532.00 | 5895.50 | 0.9383 | 0.7711 |
| SK-BR-3 | Methotrexate | 1 | uM | 3 | 5000.00 | 4101.40 | 3135.00 | 5895.50 | 0.5318 | -0.4015 |